Skip to main content
An official website of the United States government

Naltrexone Treatment for Prolonged Grief Disorder (PGD)

Sponsor
Weill Medical College of Cornell University
Status
Terminated
NCT ID
NCT04547985
This is a study to see how effective oral naltrexone is as treatment for prolonged grief disorder (PGD). Participants will take their assigned medication for 8 weeks, with monthly visits to assess symptom severity, social connectedness, and adverse reactions.
Intervention
Naltrexone HCl 50 MG Oral Tablet, Placebo
Condition
Prolonged Grief Disorder
Investigators
Holly G Prigerson, PhD

See list of participating sites